Vir: New Research Describes Structure of SARS-CoV-2 Omicron Immune Evasion, Receptor Engagement

– Growing body of evidence validates Vir’s approach of targeting a highly conserved region of the spike protein –

– Together with recent pseudo- and live virus results, additional preclinical data reinforce sotrovimab retains in vitro neutralizing activity against all known variants of concern, including the highly divergent Omicron variant –

https://www.biospace.com/article/releases/vir-biotechnology-announces-new-research-describing-the-structural-basis-of-sars-cov-2-omicron-immune-evasion-and-receptor-engagement/